Elaine Ullian, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 5,000 shares at $95.26 ($476K) on 2014-07-01, disclosed to the SEC on 2014-07-03.
Scheduled sale ($476k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.09 | 200 | $19K | 4.0% |
| 2 | $95.26 | 4,800 | $457K | 96.0% |
| Total | $95.21 avg | 5,000 | $476K | 100% |
| Filing → |
| HOLX | SELL | 2017-07-06 | $801K | — | Filing → |
| HOLX | SELL | 2017-06-06 | $786K | — | Filing → |
| HOLX | SELL | 2017-05-05 | $799K | — | Filing → |